Upregulation of mir650 down-regulates processes of ING4 favoring HCC tumorigenesis, while it targets ING4, cyclin dependent kinase 1 (CDK1) and early B-cell factor 3 (EBF3) molecules towards CLL prognosis. Here, MIR650 is linked to hepatocellular carcinoma.